929O_PR ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis
Authors
Clamp, Andrew RMcNeish, I
Dean, A
Gallardo, D
Weon-Kim, J
O'Donnell, D
Hook, J
Coyle, C
Blagden, S
Brenton, J
Naik, R
Perren, T
Sundar, S
Cook, A
James, E
Swart, A
Stenning, S
Kaplan, R
Ledermann, J
Affiliation
Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UKIssue Date
2017-09
Metadata
Show full item recordCitation
929O_PRICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis 2017, 28(suppl_5): Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx440.039Additional Links
http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx440.039/4109951/929OPRICON8-A-GCIG-phase-III-randomised-trialType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx440.039